ID   NMS-2PC
AC   CVCL_L810
DR   Wikidata; Q54930842
RX   PubMed=9849858;
RX   PubMed=32642732;
CC   Population: Japanese.
CC   Doubling time: 44.7 hours (PubMed=9849858).
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4662 ! NMS-2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=9849858; DOI=10.1007/s004280050271;
RA   Imaizumi S., Motoyama T., Ogose A., Hotta T., Takahashi H.E.;
RT   "Characterization and chemosensitivity of two human malignant
RT   peripheral nerve sheath tumour cell lines derived from a patient with
RT   neurofibromatosis type 1.";
RL   Virchows Arch. 433:435-441(1998).
//
RX   PubMed=32642732; DOI=10.1093/noajnl/vdz049; PMCID=PMC7317054;
RA   Pemov A., Li H., Presley W., Wallace M.R., Miller D.T.;
RT   "Genetics of human malignant peripheral nerve sheath tumors.";
RL   Neurooncol. Adv. 2:i50-i61(2020).
//